[HTML][HTML] COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: a multicenter interventional study
S Alsharidah, M Ayed, RM Ameen, F Alhuraish… - International Journal of …, 2021 - Elsevier
Objective To study the effectiveness of COVID-19 convalescent plasma (CCP) therapy for
patients with moderate and severe COVID-19 disease. Methods This non-randomized …
patients with moderate and severe COVID-19 disease. Methods This non-randomized …
COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study
S Alsharidah, M Ayed, RM Ameen… - … publication of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective To study the effectiveness of COVID-19 convalescent plasma (CCP) therapy for
patients with moderate and severe COVID-19 disease. Methods This non-randomized …
patients with moderate and severe COVID-19 disease. Methods This non-randomized …
COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study.
S Alsharidah, M Ayed, RM Ameen… - … Journal of Infectious …, 2020 - europepmc.org
Objective To study the effectiveness of COVID-19 convalescent plasma (CCP) therapy for
patients with moderate and severe COVID-19 disease. Methods This non-randomized …
patients with moderate and severe COVID-19 disease. Methods This non-randomized …
COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study
S Alsharidah, M Ayed, RM Ameen… - International Journal of …, 2021 - ijidonline.com
Objective To study the effectiveness of COVID-19 convalescent plasma (CCP) therapy for
patients with moderate and severe COVID-19 disease. Methods This non-randomized …
patients with moderate and severe COVID-19 disease. Methods This non-randomized …
COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: a multicenter interventional study.
S Alsharidah, M Ayed, RM Ameen, F Alhuraish… - 2021 - cabidigitallibrary.org
Objective: To study the effectiveness of COVID-19 convalescent plasma (CCP) therapy for
patients with moderate and severe COVID-19 disease. Methods: This non-randomized …
patients with moderate and severe COVID-19 disease. Methods: This non-randomized …
[PDF][PDF] COVID-19 Convalescent Plasma Treatment of Moderate and Severe Cases of SARS-CoV-2 Infection: A Multicenter Interventional Study
FR Alshammari, A Embaireeg, M Almelahi, M Adel… - academia.edu
Objective: To study the effectiveness of CCP therapy for moderate and severe COVID-19
disease patients in Kuwait. Methods: This non-randomized prospective cohort study was …
disease patients in Kuwait. Methods: This non-randomized prospective cohort study was …
[HTML][HTML] COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study
S Alsharidah, M Ayed, RM Ameen… - … Journal of Infectious …, 2021 - ncbi.nlm.nih.gov
Objective To study the effectiveness of COVID-19 convalescent plasma (CCP) therapy for
patients with moderate and severe COVID-19 disease. Methods This non-randomized …
patients with moderate and severe COVID-19 disease. Methods This non-randomized …
COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study.
S Alsharidah, M Ayed, RM Ameen… - … Journal of Infectious …, 2020 - europepmc.org
Objective To study the effectiveness of COVID-19 convalescent plasma (CCP) therapy for
patients with moderate and severe COVID-19 disease. Methods This non-randomized …
patients with moderate and severe COVID-19 disease. Methods This non-randomized …